Group 2—Intermediate epilepsy/metabolic disorders (Ion-channel and neuronal-excitability phenotype): This group comprised patients harboring variants in SCN2A, PAH, IQSEC2, and GNPAT. The gene discussed is SCN2A; the disease is Other metabolic disease.